IFNG and COVID-19: We found that at least 50% of uninfected and pre-COVID-19 individuals demonstrated cross-reactive immune responses to SARS-CoV-2 proteins (Fig. 2A), with 11/17 SARS-CoV-2-negative individuals having detectable IFN-γ responses, which were generally observed at lower frequencies than for convalescent individuals.